4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-13-013362
Options or other derivatives
- Chief Executive Officer acquired 8,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LANGECKER PETER · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2013-02-27 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +8,333 | 8,333 | D |
Loading xslF345X03/rrd372254.xml…